One molecule of this kind is the neurotensin (NT) for which it has been previously demonstrated to have the potential to target tumours such as: pancreatic cancer [1,2,3], colorectal cancer [4,5,6], lung cancer [6], prostate cancer [7,8] or breast cancer [9]. This evidence concerns the gene NTS and lung carcinoma.